Bleselumab

Bleselumab
Monoclonal antibody
TypeWhole antibody
SourceHuman
TargetCD40
Clinical data
Other namesASKP1240
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
KEGG
Chemical and physical data
FormulaC6412H9906N1690O2018S38
Molar mass144175.87 g·mol−1

Bleselumab (INN; development code ASKP1240) is a human monoclonal antibody designed for the prevention of organ transplant rejection.

This drug was developed by Kyowa Kirin Pharmaceutical Development Inc.